Legacy Capital Wealth Partners’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$823K Sell
14,914
-4,872
-25% -$264K 0.17% 125
2025
Q4
$970K Sell
19,786
-1,888
-9% -$88.1K 0.21% 96
2025
Q3
$935K Buy
21,674
+60
+0.3% +$2.34K 0.2% 102
2025
Q2
$830K Sell
21,614
-252
-1% -$9.63K 0.19% 109
2025
Q1
$847K Buy
21,866
+5,778
+36% +$212K 0.21% 101
2024
Q4
$544K Sell
16,088
-23,681
-60% -$852K 0.13% 156
2024
Q3
$1.63M Buy
39,769
+20,211
+103% +$827K 0.33% 61
2024
Q2
$753K Buy
+19,558
New +$823K 0.19% 99
2024
Q1
Sell
-18,285
Closed -$678K 206
2023
Q4
$678K Sell
18,285
-664
-4% -$23.8K 0.19% 111
2023
Q3
$687K Buy
+18,949
New +$673K 0.19% 113
2023
Q2
Sell
-13,743
Closed -$489K 121
2023
Q1
$489K Buy
+13,743
New +$481K 0.13% 138

Other funds holding GSK